Drug Profile
Research programme: anti-infectives - NeED Pharmaceuticals
Alternative Names: ND-200; ND-401; ND-701; ND-801; ND-901Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator NeED Pharmaceuticals
- Class Azoles; Carbamates; Quinolones
- Mechanism of Action CCR5 receptor antagonists; CXCR4 receptor antagonists; DNA gyrase inhibitors; DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported HIV infections; Malaria; Tuberculosis
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in HIV-infections in Italy
- 16 Jul 2016 No recent reports of development identified for preclinical development in Malaria in Italy
- 16 Jul 2016 No recent reports of development identified for preclinical development in Tuberculosis in Italy